Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of RVPH will rise by +20.87% over the next 2 Weeks and hit $0.64 by Wednesday, July 22, 2026. In that time frame, RVPH's share price is expected to range between $0.54 and $0.74.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Jul 22, 2026 | 0.54 | 0.64 | 0.74 |
| Jul 21, 2026 | 0.57 | 0.66 | 0.75 |
| Jul 20, 2026 | 0.57 | 0.66 | 0.76 |
| Jul 17, 2026 | 0.56 | 0.65 | 0.75 |
| Jul 16, 2026 | 0.53 | 0.63 | 0.73 |
| Jul 15, 2026 | 0.50 | 0.60 | 0.70 |
| Jul 14, 2026 | 0.52 | 0.62 | 0.72 |
| Jul 13, 2026 | 0.52 | 0.62 | 0.72 |
| Jul 10, 2026 | 0.52 | 0.61 | 0.71 |
| Jul 9, 2026 | 0.49 | 0.58 | 0.68 |
RVPH shares fell -15.20% in Wednesday, July 8, 2026's trading session, dropping from a previous close of $0.63 to move at $0.53. The stock demonstrated notable intraday movement (see RVPH's key stats for a full breakdown), fluctuating between $0.53 and $0.60, a +13.21% trading range. While recent weeks have seen some volatility, RVPH has managed to secure a -15.27% drop over the past 2 weeks. The downward price movement was accompanied by decreased trading volume, with approximately 99.9K shares changing hands, 139 fewer than the previous session. This amounted to $52.94K in total market activity.
Will RVPH Continue Its Upward Trend?
According to analyst ratings and projections for RVPH, Reviva Pharmaceuticals Holdings, Inc. shares are anticipated to increase by +28.02%, potentially reaching $0.74 per share by July 22, 2026. Short-term technical indicators currently suggest a bullish sentiment for RVPH. However, the stock has recorded 16 negative trading days within the past 30 sessions. Based on the RVPH stock forecast, now is a good time to buy RVPH stock because its current trading price is -17.27% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on RVPH covering social and institutional perspectives.
RVPH Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into RVPH's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 34.16% to 39.62%) suggest the stock is in a weak bearish momentum phase. The 50-day RSI, at 38.72%, hints at potential weakness developing in the medium term. Additionally, the 100-day RSI, at 42.75%, maintains a neutral outlook for the long term. Insights into RVPH's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Reviva Pharmaceuticals Short-Term Forecasts
RVPH Forecast For Next 5 Days
Our algorithm anticipates Reviva Pharmaceuticals (RVPH) stock could hit $0.61 by Jul 15, 2026. This represents a +14.38% rise from today's price, following a +3.94% change over the past five days.
RVPH Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Reviva Pharmaceuticals Holdings, Inc. (RVPH) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $0.51, which would mean a -3.77% decrease from the current price of $0.53. Projections for this period range from a high of $0.80 to a low of $0.26.
RVPH Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Reviva Pharmaceuticals's price over the next three months point to a drop. RVPH stock is expected to peak at $2.69 on Sep 23, 2026 before potentially dipping to $0.00 on Oct 09, 2026. On average, RVPH is likely to trade around $0.46 in the coming 90 days.
Reviva Pharmaceuticals Stock Forecast 2025
Based on our predictive models, Reviva Pharmaceuticals (RVPH) is expected to trade between $0.00 and $2.69 throughout 2026. This would result in an average price of $0.33, potentially offering investors a -37.74% return from current levels.
Reviva Pharmaceuticals Holdings, Inc. Monthly Forecast 2026–2027
July 2026
According to our latest forecast models, Reviva Pharmaceuticals Holdings, Inc. (RVPH) is positioned to show a strong performance in July 2026. The price is predicted to move between $0.00 and $2.54, settling at an average of $0.45. This could translate to a -15.09% loss.
August 2026
Based on current market signals, Reviva Pharmaceuticals Holdings, Inc. is projected to trend august 2026. We forecast a trading range from $0.00 to $2.60, with a likely average price of $0.32. Investors could expect a potential return of -39.62%.
September 2026
Our predictive algorithms indicate Reviva Pharmaceuticals Holdings, Inc. stock may see a shift in September 2026. The expected range spans $0.00–$2.69, with an average target of $0.58. This represents a positive outlook and a possible gain of +9.43%.
October 2026
Analyzing established trends, Reviva Pharmaceuticals Holdings, Inc. looks set to move in October 2026. Projections place the stock between $0.00 and $2.56, averaging around $0.28. This suggests a -47.17% loss from current levels.
November 2026
Market indicators suggest Reviva Pharmaceuticals Holdings, Inc. could experience notable changes during November 2026. Prices could fluctuate within $0.00 to $2.42, with a midpoint forecast of $0.12. The stock might deliver a -77.36% loss.
December 2026
Forecasting for December 2026, models estimate that Reviva Pharmaceuticals Holdings, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $2.57, averaging $0.25. This signals a cautious trajectory with potential returns around -52.83%.
January 2027
According to our latest forecast models, Reviva Pharmaceuticals Holdings, Inc. (RVPH) is positioned to show a strong performance in January 2027. The price is predicted to move between $0.00 and $2.34, settling at an average of $0.25. This could translate to a -52.83% loss.
February 2027
Based on current market signals, Reviva Pharmaceuticals Holdings, Inc. is projected to trend february 2027. We forecast a trading range from $0.00 to $2.30, with a likely average price of $0.27. Investors could expect a potential return of -49.06%.
March 2027
Our predictive algorithms indicate Reviva Pharmaceuticals Holdings, Inc. stock may see a shift in March 2027. The expected range spans $0.00–$2.31, with an average target of $0.11. This represents a cautious outlook and a possible loss of -79.25%.
April 2027
Analyzing established trends, Reviva Pharmaceuticals Holdings, Inc. looks set to move in April 2027. Projections place the stock between $0.00 and $2.33, averaging around $0.05. This suggests a -90.57% loss from current levels.
May 2027
Market indicators suggest Reviva Pharmaceuticals Holdings, Inc. could experience notable changes during May 2027. Prices could fluctuate within $0.00 to $2.08, with a midpoint forecast of $0.07. The stock might deliver a -86.79% loss.
June 2027
Forecasting for June 2027, models estimate that Reviva Pharmaceuticals Holdings, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $2.10, averaging $0.03. This signals a cautious trajectory with potential returns around -94.34%.
July 2027
According to our latest forecast models, Reviva Pharmaceuticals Holdings, Inc. (RVPH) is positioned to show a strong performance in July 2027. The price is predicted to move between $0.00 and $1.95, settling at an average of $0.03. This could translate to a -94.34% loss.
RVPH's history of dividends and stock splits also plays a role in long-term investor confidence.

